Clinical lab utilization review of highest volume tests recommended by HHS Inspector General.
This article was originally published in The Gray Sheet
Executive Summary
CLINICAL LAB UTILIZATION REVIEW OF HIGHEST VOLUME TESTS RECOMMENDED by the HHS Inspector General in a model compliance plan released Feb. 24. Laboratories should take steps to determine whether physicians are being encouraged to order medically unnecessary tests by tracking the top 30 tests they perform for Medicare beneficiaries and making a "reasonable inquiry" if utilization grows by more than ten percent in a year. Upon request, labs should be able to provide documentation supporting the medical necessity of an ordered service, the document says.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.